16 results
6-K
EX-1.1
MREO
Mereo Biopharma Group Plc
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
or such other time as agreed by the Company and the Representative.
“General Disclosure Package” means any Issuer General Use Free Writing Prospectuses … of (A) the General Disclosure Package or (B) any individual Issuer Limited Use Free Writing Prospectus, when considered together with the General
F-1/A
f9fnr arugnxbiaq
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
0i5iz02 4nko9kcbolee
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
EX-10.1
8rgq7v9092jcm
3 Sep 19
Current report (foreign)
4:05pm
6-K
nzbg3iyhy2zf6 5kdc8
3 Sep 19
Current report (foreign)
4:05pm
20-F
vqw4a3st796aej 9z1g
29 Apr 19
Annual report (foreign)
4:59pm
6-K
3qu2i v189hyy2faflo
29 Apr 19
Current report (foreign)
12:09pm
F-4
EX-10.24
it9j2se
25 Jan 19
Registration of securities (foreign)
12:00am
425
qyohyc9ynq28e3ek86i
7 Jan 19
Business combination disclosure
11:50am
425
e51ze3rokmvz2xdej9
11 Dec 18
Business combination disclosure
1:16pm
425
a69paj4x2uo57 q5a
6 Dec 18
Business combination disclosure
2:28pm
- Prev
- 1
- Next